News

TCM Ltd share price ticked higher by 0.12% to Rs 43.05. The Company`s net profit softened by 1.84% to Rs 1.6 crore, while revenue from operations slipped slightly by 0.81% to Rs 4.88 crore in Q2FY26 over Q1FY26. The market capitalization of Commodity Chemicals industry group stocks on BSE stood at Rs 1.63 lakh crore, gaining 9.93%. It has eased by 1.41% over last one week and ticked higher by 0.15% in last one month while the market capitalization of TCM Ltd has slipped by 6.42% and 1.68% in the same period respectively. Profit before tax (PBT) of TCM Ltd stood at Rs 1.6 crore in Q2 FY26, tanking 33.05% year-on-year, and declining 1.84% quarter-on-quarter. EBITDA came in at Rs 1 crore, crashing by 48.51% YoY and plunging by 24.64% sequentially. Total expenses marginally dropped 3.99% to Rs 6.02 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 2.93 crore, easing 0.34% YoY, while employee benefits expense was at Rs 1.09 crore, tumbling by 24.31% YoY. For the TTM ended FY26, revenue from operations declined by 19.30% to Rs 26.01 crore, while net profit tanked by 161.14% to Rs 1.4 crore, compared to previous TTM. EBITDA plunged by 362% to Rs 6.63 crore, and PBT collapsed by 160.89% to Rs 1.37 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 10.08 crore in FY26, as against Rs 1.95 crore in FY25. TCM Ltd jumped 11.36% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 2.83% during the same period.

TCM will hold a meeting of the Board of Directors of the Company on 13 August 2026.

Net loss of TCM reported to Rs 1.65 crore in the quarter ended March 2026 as against net profit of Rs 4.03 crore during the previous quarter ended March 2025. Sales declined 35.69% to Rs 4.92 crore in the quarter ended March 2026 as against Rs 7.65 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 5.81 crore in the year ended March 2026 as against net profit of Rs 1.61 crore during the previous year ended March 2025. Sales declined 24.11% to Rs 19.74 crore in the year ended March 2026 as against Rs 26.01 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales4.927.65 -36 19.7426.01 -24 OPM %-23.580.78 --22.80-8.30 - PBDT-1.454.09 PL -5.471.72 PL PBT-1.633.99 PL -6.021.37 PL NP-1.654.03 PL -5.811.61 PL Powered by Capital Market - Live News

TCM will hold a meeting of the Board of Directors of the Company on 26 May 2026.

Net Loss of TCM reported to Rs 1.14 crore in the quarter ended December 2025 as against net loss of Rs 0.86 crore during the previous quarter ended December 2024. Sales declined 7.93% to Rs 5.69 crore in the quarter ended December 2025 as against Rs 6.18 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales5.696.18 -8 OPM %-9.67-9.71 - PBDT-1.00-0.81 -23 PBT-1.18-0.90 -31 NP-1.14-0.86 -33 Powered by Capital Market - Live News